Vioxx

Tuesday, June 29, 2010 at 3: 08 p.m. VIOXX RULING: Merck & Co. wins the first trial over Vioxx brought by a state trying to recoup what it paid for residents to take the painkiller withdrawn from the market because it doubled cardiovascular risks.

Fore, right! 2010

Just how involved Merck's lawyers were in Vioxx-related corporate spin remains to be seen, but lots of lawyer input into scientific issues would raise some troubling issues.

The Legal Underground: 2007

Merck would seem to have one big thing in its favor: the company voluntarily withdrew Vioxx from the market.

Coyote Blog » Blog Archive » Safety Requires Honest Discussions Which Torts Punish 2005

Merck would seem to have one big thing in its favor: the company voluntarily withdrew Vioxx from the market.

Coyote Blog » 2005 » January 2005

Merck would seem to have one big thing in its favor: the company voluntarily withdrew Vioxx from the market.

Coyote Blog » 2005 » January 2005

It's a hunch that's been confirmed by a recent article from Law. com, "Awash in Vioxx Suits, Merck Is Recruiting Big-Time Help," which states:

For the Defense 2005

Celebrex Gets a Reprieve: Celebrex, a close relative of Vioxx, is managing to hold its own in the heart safety contest:

Archive 2004-12-01 2004

Celebrex Gets a Reprieve: Celebrex, a close relative of Vioxx, is managing to hold its own in the heart safety contest:

Medpundit 2004

The jury ruled against co-plaintiff Thomas Cona, however, as documentation of the 54-year-old's long-term Vioxx use was seen as inadequate.

Merck Continues To Fight For Vioxx 2006

Banc of America Securities said the lawsuits for long-term Vioxx users will be more challenging than prior cases and could cause near-term volatility for the stock.

Eye On Stocks For Monday, March 6Eye On Stocks For Monday, March 6, 2006 2006